Janux Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Janux Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Janux Therapeutics Inc
Rating: 1.18183325
Author: Trendlyne DVM scores

about

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (...

23.98 0.04 (0.17%)

66.56% Fall from 52W High

429.8K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.3 / 100

Technically Neutral

35.9 / 100

1Yr Price target upside is 241%

14 analysts

Janux Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Janux Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (...

66.56% Fall from 52W High

SWOT Analysis

Janux Therapeutics Inc Live Price Chart